e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
Today 8:05 EST
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
December 01, 2025
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization
November 12, 2025
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities
November 10, 2025
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.
October 20, 2025
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology
July 30, 2025
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
April 30, 2025
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory
April 15, 2025
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy
March 07, 2025
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper
March 05, 2025
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
September 25, 2024
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
September 13, 2024
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
September 12, 2024
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
September 11, 2024
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd
August 27, 2024
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd
August 26, 2024
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
April 18, 2024
From
BioNexus Gene Lab Corp.
Via
GlobeNewswire
Tickers
BGLC
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.